Cansortium Commences Edibles Sales in Florida Following Receipt of Regulatory Approval
Cansortium Inc. announced the launch of its edibles line, Fluent Gels, in Florida's dispensaries after receiving regulatory approval from the Florida Department of Health. The edibles, available in three flavors and pre-dosed with 10mg of THC, cater to the growing demand among medical marijuana patients. CEO Robert Beasley emphasized the company's operational excellence and strong partnerships in developing premium cannabis products. Cansortium aims to expand its offerings while maintaining high-quality standards in its dispensaries across Florida.
- Launch of Fluent Gels edibles, catering to patient demand.
- Products developed in collaboration with established partner Smokiez.
- Strong operational capabilities in cultivation, processing, and retail.
- Commitment to high-quality, compliant cannabis products.
- None.
MIAMI, Oct. 13, 2020 /PRNewswire/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE: TIUM.U), (OTCQB: CNTMF), a vertically-integrated provider of premium-quality medical Cannabis operating under the Fluent™ brand, today announced that it has received approval from the Florida Department of Health and will commence sales of edibles today in each of its Fluent dispensaries in the state. The Company was well-positioned to react to the emergency rules issued by DOH at the end of August and quickly move through the regulatory approval process. Edibles represents a route of delivery eagerly anticipated by medical marijuana patients in Florida.
Fluent's first edibles product line, Fluent Gels, are bite-sized pieces that are initially available in three flavors: Watermelon, Green Apple and Blue Raspberry. They are sold in packages of 10 pieces, each pre-dosed with 10mg of THC. Fluent Gels have been handcrafted in partnership with Smokiez, known nationwide for their edible products, and are vegan, gluten-free, non-dairy and contain no high fructose corn syrup. The Company expects to continue to expand its edibles offerings to meet patient demand.
Cansortium Chief Executive Officer, Robert Beasley, commented, "I'm pleased to have our first batches of Fluent Gels rolling into the Florida market. It's an exciting time for the industry. Our partnership helped us tremendously in getting everything prepped and assuring our success in creating the best edible products, Fluent Gels."
The Fluent brand continually strives to set the standard for premium quality, consistently formulated cannabis products. Each of the Company's Florida dispensaries carries a complete assortment of Fluent premium dried flower and full-spectrum concentrates and cartridges as well as creams, drops, capsules, and suppositories. All Fluent products in the Company's Florida dispensaries use high-quality cannabis that is cultivated, processed, and packaged in the Company's Florida facility in strict compliance with Florida regulations. For consumers, the sleek, modern dispensaries provide a warm, welcoming, professional environment, with private consultation rooms and knowledgeable staff who carefully guide patients in selecting the right products and carefully safeguard patient privacy.
For a complete list of Fluent dispensary locations, current promotions and rewards programs and hours of operation, or to explore the entire Fluent product line and place an online order for home delivery anywhere in Florida, visit https://getfluent.com/.
About Cansortium Inc.
Headquartered in Miami, Florida, and operating under the Fluent™ brand, Cansortium is focused on being the highest quality cannabis company in the State of Florida driven by an unrelenting commitment to operational excellence from seed to sale. Cansortium has developed strong proficiencies in each of cultivation, processing, retail, and distribution activities, resulting in successfully operating in the highly regulated cannabis industry. In addition to Florida, Cansortium seeks to create significant shareholder value in the attractive markets of Texas, Michigan, and Pennsylvania, where the Company has secured licenses and established operations.
Cansortium Inc.'s common shares and warrants trade on the CSE under the symbol "TIUM.U" and "TIUM.WT.U", respectively, and on the OTCQB Venture Market under the symbol (OTCQB: CNTMF). Investors can find current financial disclosure and Real-Time Level 2 quotes for the Company on www.otcmarkets.com.
Forward-Looking Information
Certain information in this news release may constitute forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates, and projections regarding future events.
Forward-looking information is necessarily based on many opinions, assumptions, and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in the public documents of the Company available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
View original content to download multimedia:http://www.prnewswire.com/news-releases/cansortium-commences-edibles-sales-in-florida-following-receipt-of-regulatory-approval-301151014.html
SOURCE Cansortium Inc
FAQ
When did Cansortium commence sales of edibles?
What is the stock symbol for Cansortium?
What flavors are available for Fluent Gels edibles?
How much THC is in each piece of Fluent Gels?
Where can I buy Fluent Gels in Florida?
